Original ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 60 | Issue 1 | 2026 | pp. 96–105Open access
Formulation Development and Evaluation of Transferosomal Gel Using Trifarotene
- 1*,
- 1*,
- 1*,
- 1*,
- 1*,
- 1*
- 1 Department of Pharmaceutics, Smt. B.N.B. Swaminarayan Pharmacy College, Vapi, Gujarat, INDIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Anuradha Prajapati
Department of Pharmaceutics, Smt. B.N.B. Swaminarayan Pharmacy College, Vapi, Gujarat, INDIA.
Email: anupatel03@gmail.com
Copyright: © 2026 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2026
- Received:
- Apr 8, 2025
- Accepted:
- Aug 22, 2025
- DOI:
- 10.5530/ijper.20261010
How to cite
Prajapati, A., Tandel, M., Narkhede, S. B., Desai, N., Luhar, S., & Narkhede, K. (2026). Formulation Development and Evaluation of Transferosomal Gel Using Trifarotene. Indian Journal of Pharmaceutical Education and Research, 60(1), 96–105. https://doi.org/10.5530/ijper.20261010
Abstract
Background: Trifarotene (TFT), a retinoid commonly used for acne treatment, suffers from poor water solubility, limiting its effectiveness and increasing the risk of side effects. Enhancing its bioavailability and providing sustained drug release could improve therapeutic outcomes while reducing side effects. Objectives: The study aimed to develop and optimize a transferosomal gel formulation of Trifarotene to enhance drug availability at the target site, achieve sustained release, and minimize side effects. Materials and Methods: A 3² factorial design was used to optimize the transferosome formulation, prepared via the thin lipid film hydration method using a rotary vacuum evaporator. The study varied the type and concentration of edge activators and incorporated phospholipids and surfactants into the formulation. The optimized formulation was then converted into a gel and evaluated based on particle size, Polydispersity Index (PDI), zeta potential, entrapment efficiency, and in vitro drug release percentage. Additional evaluations included excipient compatibility via Differential Scanning Calorimetry (DSC), surface morphology using Scanning Electron Microscopy (SEM), and the gel's physical characteristics (pH, viscosity, extrudability, Spreadability, and skin irritation potential). Stability studies were conducted as per ICH guidelines. Results: The optimized transferosomal gel showed favourable in vitro drug release with significant improvement in bioavailability. Independent variables, including edge activator concentration, had a statistically significant impact on the formulation's characteristics (p<0.005). Excipient compatibility was confirmed via DSC, and SEM analysis revealed suitable vesicle morphology. The gel was found to be stable, safe, and compatible with skin layers at a low dose, with no signs of skin irritation. Conclusion: The optimized Trifarotene transferosomal gel formulation enhanced drug delivery, improved skin penetration, and provided sustained release with minimal side effects, showing promise for safe and effective acne treatment.
Keywords
Subject
Article metadata
| Title | Formulation Development and Evaluation of Transferosomal Gel Using Trifarotene |
|---|---|
| Authors | Anuradha Prajapati; Muskan Tandel; Sachin B Narkhede; Neha Desai; Shailesh Luhar; Kantilal Narkhede |
| Affiliations | Department of Pharmaceutics, Smt. B.N.B. Swaminarayan Pharmacy College, Vapi, Gujarat, INDIA. |
| Corresponding author | anupatel03@gmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 60, Issue 1 (2026) |
Also in this issue
- Revolutionizing Dental Practice: A Review of Innovations in Dental Materialspp. 1–13
- 3D Bioprinting Potential Technology for Drug Deliverypp. 14–27
- A Review of Game-Based Learning in Higher Education: Exploring Escape-Room Methodologies in Educational Settingspp. 28–36
- Compromised Medical Products A Scoping review of Quality, Safety and Efficacy Concernspp. 37–53
- The Potential Effect of Plant Based Antioxidants in Breast Cancer Prevention and Treatmentpp. 54–62